Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial
Abstract Objectives The aim of this randomised GCP-controlled trial is to clarify whether combination therapy with the antibiotic azithromycin and hydroxychloroquine via anti-inflammation/immune modulation, antiviral efficacy and pre-emptive treatment of supra-infections can shorten hospitalisation...
Autores principales: | Pradeesh Sivapalan, Charlotte Suppli Ulrik, Rasmus Dahlin Bojesen, Therese Sophie Lapperre, Josefin Viktoria Eklöf, Kjell Erik Julius Håkansson, Andrea Browatzki, Casper Tidemansen, Jon Torgny Wilcke, Julie Janner, Vibeke Gottlieb, Howraman Meteran, Celeste Porsbjerg, Birgitte Lindegaard Madsen, Mia Moberg, Lars Pedersen, Thomas Lars Benfield, Jens Dilling Lundgren, Filip Krag Knop, Tor Biering-Sørensen, Muzhda Ghanizada, Tine Peick Sonne, Uffe Christian Steinholtz Bødtger, Sidse Graff Jensen, Daniel Bech Rasmussen, Eva Brøndum, Oliver Djurhuus Tupper, Susanne Wiemann Sørensen, Gitte Alstrup, Christian Borbjerg Laursen, Ulla Weinrich Møller, Asger Sverrild, Jens-Ulrik Stæhr Jensen |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
BMC
2020-06-01
|
Colección: | Trials |
Materias: | |
Acceso en línea: | http://link.springer.com/article/10.1186/s13063-020-04409-9 |
Ejemplares similares
-
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan
por: Pradeesh Sivapalan, et al.
Publicado: (2020-10-01) -
Treatment Response Biomarkers in Asthma and COPD
por: Howraman Meteran, et al.
Publicado: (2021-09-01) -
Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study
por: Peter Kamstrup, et al.
Publicado: (2021-07-01) -
Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma
por: Oliver Djurhuus Tupper, et al.
Publicado: (2021-10-01) -
The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients
por: Alexander Jordan, et al.
Publicado: (2021-10-01)